⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
Chainguard Launches Commercial Builds with Industry Leaders, Setting a New Standard for Verifiable, Zero-Vulnerability Software
prnewswire.com
ESTC
GLBZ
GRAF
TIGR
SNOW
FTNT
HPE
OPEN
CHKP
CAN
PANW
CRWD
ZS
DDOG
MDB
SMCI
AMD
NVDA
INTC
AMZN
GOOG
MSFT
IBM
ORCL
CRM
ADBE
PYPL
NFLX
CMCSA
DIS
VZ
T
KO
PEP
JNJ
PG
XOM
CVX
UNH
JPM
BAC
WFC
C
GS
MS
AMGN
GILD
BMY
PFE
MRK
ABBV
LLY
MDT
ISRG
COST
WMT
HD
MCD
SBUX
NKE
BA
CAT
GE
HON
RTX
LMT
GD
MMC
AXP
V
MA
MSCI
ADP
AMAT
ASML
QCOM
AVGO
TXN
ADSK
CDNS
SNPS
MRVL
GOOGL
Mestag Therapeutics Announces $40 Million Financing and Appoints Chief Medical Officer and Chief Development Officer in Preparation to Enter the Clinic
globenewswire.com
JNJ
MRK
East Coast Premiere for SXSW Stand Out 'Power Ballad' Starring Paul Rudd and Nick Jonas
accessnewswire.com
JNJ
Brandon Hall Group Releases 2026 Women in Leadership Magazine Inspired by Women in Leadership Summit
globenewswire.com
PFE
BAC
VZ
JNJ
Global Electrosurgical Devices Market Witnessing Strong Expansion at a CAGR of ~6% by 2034, Driven by Advanced Surgical Energy Technologies | DelveInsight
prnewswire.com
CNMD
MDT
JNJ
SN
BSX
UTMD
Detachable Embolization Coils Market Outlook 2026-2036: Global Market to Reach USD 2.8 Billion by 2036 at 5.7% CAGR
accessnewswire.com
MDT
PEN
BSX
JNJ
BIO-Europe Spring® 2026: Partnering Momentum Builds as Global Biopharma Leaders Set Course for Lisbon
globenewswire.com
JNJ
LLY
NVO
TEVA
GSK
IFNNY
Eve-of-Trial $65M Settlement Preliminarily Approved in Novel Antitrust Class Action Against J&J Subsidiary Actelion Pharmaceuticals
globenewswire.com
JNJ
Eve-of-Trial $65M Settlement Preliminarily Approved in Novel Antitrust Class Action Against J&J Subsidiary Actelion Pharmaceuticals
globenewswire.com
JNJ
Johnson & Johnson highlights promising first-in-human Erda-iDRS (formerly TAR-210) results in intermediate-risk non-muscle-invasive bladder cancer
prnewswire.com
JNJ